This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 3229
Title
Reduction, androstenedione leads to Decrease, circulating testosterone levels
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|---|---|
| Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals) | adjacent | High | High | Bérénice COLLET (send email) | Open for citation & comment |
Taxonomic Applicability
| Term | Scientific Term | Evidence | Link |
|---|---|---|---|
| mammals | mammals | High | NCBI |
Sex Applicability
| Sex | Evidence |
|---|---|
| Mixed | High |
Life Stage Applicability
| Term | Evidence |
|---|---|
| All life stages | High |
Key Event Relationship Description
This key event relationship links a decrease in androstenedione to a decrease in testosterone.
17-beta-hydroxysteroid dehydrogenase (17-beta-HSD) is an enzyme responsible for synthesis of testosterone from androstenedione, hence if androstenedione decrease, there will be a lack of substrate for this enzymatic reaction to occur, which may affect testosterone levels. Decreased levels of the precursor androstenedione results in reduced levels of testosterone (Flück, 2017; Lawrence, 2022; Naamneh Elzenaty, 2022; O’Donnell, 2022; Ye, 2014).
Evidence Collection Strategy
The KER describes a generally recognized and understood process, i.e. canonical knowledge. The aim of the literature search was therefore to identify review articles and book chapters that summarise the canonical knowledge. PubMed was searched using key words related to steroidogenesis. The search was restricted to reviews from the last 10 years.
Evidence Supporting this KER
Biological Plausibility
The synthesis of testosterone from androstenedione by 17-beta-HSD is a well-studied and generally recognized process and the biological plausibility of the KER therefore is high.
17-beta-HSD is an enzyme responsible for synthesis of testosterone from androstenedione. There are several isoforms of the enzyme. 17-beta-HSD3 is the main enzyme in humans converting androstenedione to testosterone, whereas both 17-beta-HSD1 and 17-beta-HSD3 can perform the conversion in rodents. Reduced levels of the precursor androstenedione will result in reduced levels of testosterone (Flück, 2017; Lawrence, 2022; Naamneh Elzenaty, 2022; O’Donnell, 2022; Ye, 2014).
Empirical Evidence
A high-throughput assay using the H295R cell line showed that chemical exposure that resulted in reduced androstenedione reduced testosterone levels (Karmaus, 2016).
Uncertainties and Inconsistencies
Testosterone can also be synthesised by 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD) from androstenediol. Reduced levels could therefore also be due to reduced levels of the precursor androstenediol.
Known modulating factors
Quantitative Understanding of the Linkage
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
Domain of Applicability
Taxonomic applicability
Androstenedione and testosterone are present in mammals (O'Donnell, 2022).
Life stage applicability
Androstenedione and testosterone are present from fetal period throughout life (Naamneh Elzenaty, 2022).
Sex applicability
Androstenedione and testosterone are present both in males and females (Naamneh Elzenaty, 2022).
References
Flück CE & Pandey AV (2017). Testicular Steroidogenesis. In Simoni, M & Huhtaniemi IT (Eds.) Endocrinology of the Testis and Male Reproduction. (1st ed., pp. 343-371) Endocrinology. Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-44441-3.
Karmaus AL, Colleen M. Toole, Dayne L. Filer, Kenneth C. Lewis, Matthew T. Martin, High-Throughput Screening of Chemical Effects on Steroidogenesis Using H295R Human Adrenocortical Carcinoma Cells, Toxicological Sciences, Volume 150, Issue 2, April 2016, Pages 323–332, https://doi.org/10.1093/toxsci/kfw002
Lawrence BM, O’Donnell L, Smith LB, and Rebourcet D. 2022. ‘New Insights into Testosterone Biosynthesis: Novel Observations from HSD17B3 Deficient Mice.’ International Journal of Molecular Sciences 23 (24). https://doi.org/10.3390/ijms232415555.
Naamneh Elzenaty R, du Toit T, and Flück CE. 2022. ‘Basics of Androgen Synthesis and Action.’ Best Practice & Research. Clinical Endocrinology & Metabolism 36 (4): 101665. https://doi.org/10.1016/j.beem.2022.101665.
O’Donnell L, Whiley PAF, and Loveland KL. 2022. ‘Activin A and Sertoli Cells: Key to Fetal Testis Steroidogenesis.’ Frontiers in Endocrinology 13: 898876. https://doi.org/10.3389/fendo.2022.898876.
Ye L, Guo J, and Ge RS. 2014. ‘Environmental Pollutants and Hydroxysteroid Dehydrogenases.’ Vitamins and Hormones 94: 349–90. https://doi.org/10.1016/B978-0-12-800095-3.00013-4.